MARINUS PHARMACEUTICALS, INC.·4

Jan 30, 4:21 PM ET

Nochur Sara 4

4 · MARINUS PHARMACEUTICALS, INC. · Filed Jan 30, 2023

Insider Transaction Report

Form 4
Period: 2023-01-26
Nochur Sara
Director
Transactions
  • Award

    Common Stock

    2023-01-26+3,6006,350 total
  • Award

    Stock Option (Right to Buy)

    2023-01-26+16,20016,200 total
    Exercise: $5.94Exp: 2033-01-26Common Stock (16,200 underlying)
Footnotes (2)
  • [F1]Represents the grant of restricted stock units (RSUs). The RSUs vest in full on January 26, 2024, subject to the reporting person's continued service with Marinus Pharmaceuticals, Inc. (the Issuer). Each RSU represents the right to receive one share of common stock of the Issuer.
  • [F2]The option vests and becomes exercisable in 12 equal monthly installments beginning on February 26, 2023, subject to the reporting person's continued service with the Issuer.

Documents

1 file
  • 4
    form4-01302023_090141.xmlPrimary